EPCCS

The European Primary Care Cardiovascular Society (EPCCS) launches aiming to facilitate the improvement of cardiovascular care in a primary care

[EPCCS @EPCCS]

EPCCS Annual Cardiovascular Summit 2026 https://t.co/4s8kEfju7h

[Radcliffe Cardiology @radcliffeCARDIO]

💬 97% would recommend Advancements in Obesity Management to a colleague
⭐ 98.2% rated content very good or excellent
🔄 96.6% said it could change clinical practice

Advancements in Obesity Management 2025 brought together an incredible global faculty: Harold Bays, Naveed Sattar, Lydia Alexander, @carel_leroux , @AlexanderMiras, @helen_parretti and Liesbeth van Rossum.

If you didn't get to watch it live or want to rewatch it, #AOM25 is now available to watch on demand 👉 https://t.co/JkS1cp97ya

[EPCCS @EPCCS]

Elderly people also benefit from lipid-lowering therapy for primary prevention

Read more:
https://t.co/jP1lUy0kUD

#CardioTwitter #lipidlowering #lipids #primaryprevention #eldery #LDLc #CVD #riskreduction

[EPCCS @EPCCS]

Daily step counts to reduce mortality and CVD risks for healthy individuals

A meta-analysis showed that walking ~8800 steps/day lowered mortality risk by 60%, while a daily step count of ~7200 reduced CVD risk by 51%.

Read: https://t.co/hcHP2Zr9LU

#CardioTwitter #CVD #steps

[EPCCS @EPCCS]

Consistent benefit of SGLT2 inhibitors on CV outcomes across various patient populations

Read: https://t.co/2YUXq6VmzH

#SGLT2 #CVD #Cardiotwitter #T2D #HF #CKD #diabetes #heartfailure #comorbidity

[EPCCS @EPCCS]

Global association of the PURE healthy diet score with health outcomes

Read: https://t.co/U7ixiS1SFA

#diet #CVD #mortality #dietscore #PUREhealthyscore

[EPCCS @EPCCS]

The AHA has published a scientific statement on the cardiopulmonary impact of e-cigarettes and vaping products. Read more: https://t.co/CNeTyMT18I

The use of e-cigarettes and vaping products is increasing in the US. Do you see an increased usage of these products in Europe?#poll

[EPCCS @EPCCS]

Results for oral PCSK9 inhibitor promising to proceed to phase 3 trials.
Watch: https://t.co/1qBV0cZzkI
#oralPCSK9i #PCSK9inhibitor #LDLc #CVD

[EPCCS @EPCCS]

Association of self-reported keto diet with LDL-c and apoB levels and CV events.
Read: https://t.co/GK0Lj2X0Ar
#ketodiet #LDLc #apoB #diet #CVD

[EPCCS @EPCCS]

Association between lifelong endurance exercise and higher coronary plaque burden
Read: https://t.co/BniuBvLuRD
#exercise #plaques #CVD

[EPCCS @EPCCS]

Fitting in bempedoic acid in the arsenal of lipid-lowering therapies.
Watch:
https://t.co/cFhKUZvnur
#bempedoicacid #LDLc #lipids #CLEAROutcomes #CVD

[EPCCS @EPCCS]

Triglyceride-rich lipoproteins as residual CV risk in patients on statins.
Watch: https://t.co/PXODi533cV
#CVD #lipids #triglycerides #statines

[EPCCS @EPCCS]

Two DOACs compared for recurrent VTE and bleeding in patients with VTE
Read: https://t.co/ofrbzeWonq
#DOAC #VTE #thrombosis #bleeding

[EPCCS @EPCCS]

In lower-income countries, association of prolonged sitting with mortality is more pronounced
Read: https://t.co/jAqAcUO1si
#sitting #CVD

[EPCCS @EPCCS]

What are potential mechanisms of benefit of icosapent ethyl?
Watch a video by Prof. Packard: https://t.co/wViSke4j7w
#icosapentethyl #fishoils #omega3FAs #CVD

[EPCCS @EPCCS]

"During the pandemic, we have lost sight of long-term conditions that are the biggest contributors to worse outcomes", says prof. Hobbs. "We need to restart and catch up in CVD prevention ASAP."
Watch: https://t.co/rmzLVonGNd

[EPCCS @EPCCS]

SGLT2i approved by EC for chronic HF regardless of ejection fraction.
Read: https://t.co/Qd2rxhBTK3
#heartffailure #SGLT2inhibitor #FDAapproval

[EPCCS @EPCCS]

Comparing two GLP-1RAs with regard to weight loss in overweight and obese adults.
Read: https://t.co/ZGxwPCsg68
#GLP1RA #overweight #obesity #weightloss

[EPCCS @EPCCS]

You need to measure iron deficiency in HF and treat it: https://t.co/VoTx18f8I0
#irondeficiency #heartfailure #iron #CVD

[EPCCS @EPCCS]

A meta-analyis on the worldwide prevalence of statin intolerance.
Read: https://t.co/dpj8wnsi4D
#statinintolerance #statins #LDLc #CVD